CREON has exceptional coverage
CREON is widely accepted on most national health plans
90 %
of covered lives have preferred coverage and the lowest branded co-pay or co-insurance with commercial insurance and Medicare Part D2*
90 %
unrestricted commercial and Medicare Part D coverage with no prior authorization2†‡
Medicare Part D coverage for more patients than any other PERT2§
89% preferred commercial coverage with the lowest branded co-pay2*
Products listed here are not interchangeable. Material differences exist between products. Consult each individual product’s United States Prescribing Information for full details.
93% preferred Medicare Part D coverage with the lowest branded co-pay or co-insurance2*
Products listed here are not interchangeable. Material differences exist between products. Consult each individual product’s United States Prescribing Information for full details.
Use the formulary lookup tool to see which plans in your area provide coverage for CREON.
*As of 02/2024. Preferred coverage varies by channel: national commercial (89%) and Medicare Part D (93%).1
†As of 02/2024. Unrestricted coverage varies by channel: national commercial (89%) and Medicare Part D (93%). Unrestricted coverage indicates no step edit.1
‡Plan coverage terms regarding PA may vary. Medical necessity or other documentation requirements may apply.
§CREON is on the formulary tier status designated by the insurer as the lowest branded copay (commercial) or co-insurance (Medicare Part D) in the therapeutic class. AbbVie co-pay programs are applicable only to commercial plan coverage. Co-pay programs may not be applied to Medicare Part D or other government plans.
CREON is on a preferred tier or otherwise has preferred status on the plan’s formulary. CREON is on the formulary tier status designated by the insurer as the lowest branded copay in the therapeutic class. Unrestricted implies no step edit.
PERT = pancreatic enzyme replacement therapy.